Vorinostat Completed Phase 1 Trials for Small Intestine Cancer / Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00561418Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma